Hirsutism II: Treatment

    August 1998 in “ Australasian journal of dermatology ”
    Richard Young, Rodney Sinclair
    Image of study
    TLDR The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.
    The document from 1998 discusses various treatments for hirsutism, which include both cosmetic and pharmacological approaches. Cosmetic treatments mentioned are bleaching, plucking, electrical epilation, and laser epilation. On the pharmacological side, anti-androgens such as spironolactone and cyproterone acetate are used to block androgen receptors. Additionally, oral contraceptives and corticosteroids are noted for their role in reducing androgen expression. The document also highlights that finasteride, a follicular 5α reductase inhibitor, and flutamide, an anti-androgen, are being evaluated for their effectiveness. Furthermore, gonadotropin-releasing hormone agonists are mentioned as showing promise in reducing androgen expression and treating hirsutism.
    Discuss this study in the Community →

    Research cited in this study

    16 / 16 results

    Related Community Posts Join

    6 / 24 results

      community I am having Success with RU58841 and 1mm Derma Roller

      in Microneedling  19 upvotes 2 years ago
      A user reported success with RU58841 and a 1mm derma roller for hair regrowth, noting significant improvement in hair density and reduced scalp visibility. They also mentioned using minoxidil and black castor oil in the past, with mixed results.

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    2 / 2 results